CIBC Asset Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
CIBC Asset Management's RPRX Position: Q3 2026 in Review
CIBC Asset Management increased its Royalty Pharma (RPRX) stake by 1.3% in Q3 2026, buying an estimated $26.4K and bringing the position to 34,535 shares worth $2.02M. The position accounts for ﹤0.01% of the portfolio, ranked #653.
CIBC Asset Management first reported a position in RPRX in Q1 2021 and has held it in 20 quarters since. 707 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.
- CIBC Asset Management held 34,535 shares of Royalty Pharma worth $2.02M as of Q3 2026.
- CIBC Asset Management bought 448 Royalty Pharma shares in Q3 2026, an estimated $26.4K.
- Royalty Pharma made up ﹤0.01% of CIBC Asset Management's portfolio in Q3 2026, its #653 holding.
- CIBC Asset Management first reported a position in Royalty Pharma in Q1 2021 and has held it in 20 quarters since.
- 707 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.
Based on CIBC Asset Management's 13F filing for Q3 2026, filed 5 Nov 2026.